Alzheimer's LINX makes it easier to see the route of pathogenesis leading to cognitive decline, and devise strategies to stop it. By addressing Blood-Brain Barrier (BBB) breakdown, identifying and removing triggers and enhancing neuronal regeneration, one might be able to win the war on cognitive decline.
Clinical Use
To identify patients at greater risk for developing Alzheimer's disease or other neurological disorder.
To identify reactivity to triggers of Alzheimer's disease or other neurological disorder.
To identify the early stage of neurodegenerative processes.
To monitor the effectiveness of lifestyle modifications for Alzheimer's disease.
Recommended for Patients Who
Are interested in preventing the development of Alzheimer's disease or other neurological disorder.
Are exhibiting early signs of Alzheimer's disease or other neurological disorder.
Have been diagnosed with Alzheimer's disease.
Have a history of gastrointestinal disorders and/or diabetes.
Played high-impact sports.
Are immunoreactive against specific pathogens, chemicals and foods.